STAA (Health Care Supplies) Stock Valuation & Fair Value Significantly overvalued
STAA (Health Care Supplies) trades at a blended P/E of 1,506.9, about 1305% above its historical normal valuation, with a forward growth estimate of 502.4% and a PEG of 3.00.
Valuation flags
- Overvalued by 1305%
Frequently asked questions
Is STAA overvalued?
At a blended P/E of 1,506.9 versus its historical normal P/E of 107.3, STAA trades about 1305% above its typical valuation, with a PEG of 3.00 on 502.4% forward growth. tickerseer currently rates it significantly overvalued.
What is STAA's fair value and PEG?
STAA trades at a blended P/E of 1,506.9 against a historical normal P/E of 107.3, a PEG of 3.00, and a forward growth estimate of 502.4%.
Has tickerseer's rating of STAA changed?
tickerseer's rating has been significantly overvalued since 2026-08-07.
Industry: Health Care Supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.